News Archive - Nicole Mlynaryk

Smartly Done

Across disciplines and specialties, from cells to systems, artificial intelligence is on its way to altering how we understand and treat disease.

New Study Flips the Script on Liver Cancer

UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.

To Ward Off Aging, Stem Cells Must Take Out the Trash

UC San Diego researchers find stem cells use a surprising system for discarding misfolded proteins. This unique pathway could be the key to maintaining long-term health and preventing age-related blood and immune disorders.

UC San Diego’s Astrobiotechnology Hub to Drive Drug Discovery in Space

UC San Diego’s new Astrobiotechnology Hub brings together leaders in academia, biotechnology and aerospace industries under a united mission to advance stem cell science and commercialization in space.

(Re)introducing John

Get to know the rich history and future plans of new vice chancellor for Health Sciences, John M. Carethers.

Toddlers’ Attention to ‘Motherese’ Speech May Be Used to Diagnose Autism

Toddlers’ level of attention to "motherese" speech can be used as a biomarker for autism spectrum disorder (ASD). UC San Diego scientists developed a new eye-tracking test to measure it, which can accurately identify toddlers with a subtype of ASD.

Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies

UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.

Stress-Tolerant Cells Drive Tumor Initiation in Pancreatic Cancer

UC San Diego scientists discover a molecular pathway critical to the initiation of pancreatic tumors. The findings may inspire new chemotherapeutic drugs targeting early stages of tumor formation and spread

Tissue-Specific Immunity May Be the Future, if We Can First Learn its Rules

UC San Diego study reveals critical insights into the complex biology of tissue-specific T cells, paving the way for a new branch of precision therapeutics in immunity, autoimmunity, and cancer.